IBU
LOE ApproachingNDAORALSUSPENSION
Approved
Dec 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
2/8 — Basic
Drug data last refreshed 2d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
IBU is an oral suspension small-molecule product approved by Abbott in 1989, likely an ibuprofen-based formulation given the brand name. The drug is currently approaching loss of exclusivity, indicating it is a mature, widely-used pain or anti-inflammatory therapeutic.
LOE Approaching
With LOE approaching and moderate competitive pressure (30/100), brand defense and generic transition strategies will dominate Abbott's commercial focus.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Magnetic Ressonance Imaging of Temporomandibular Joint
Started Aug 2026
Effects of Vagus Nerve Stimulation on Temporomandibular Disorders.
Started Jun 2026
10 enrolled
TMDTemporomandibular Disorders (TMDs)
A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir
Started Apr 2026
18 enrolled
Coronavirus Disease 2019Coronavirus Disease 2019 (COVID-19)COVID-19 (Coronavirus Disease 2019)+8 more
Propel Drug-Eluting Sinus Implant Family IBUKI Cohort
Started Apr 2026
100 enrolled
Chronic Rhinosinusitis (CRS)
Vestibular Socket Therapy Using Magnesium Membrane Versus Cortical Lamina for Immediate Implant Placement in Type II Extraction Sockets
Started Mar 2026
24 enrolled
Immediate Dental Implant in Type 2 Extraction SocketVestibular Socket Therapy
Worked on IBU at Abbott? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.